Source: International Congress 2015 – COPD: interesting notes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ivan Kremis (Tomsk, Russian Federation), Ekaterina Bukreeva, Elena Gereng, Ivan Kremis. Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2015; 46: Suppl. 59, 402

Member's Comments

No comment yet.

Related content which might interest you: Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design Source: Eur Respir J 2006; 27: 293-299 Year: 2006 Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls Source: International Congress 2016 – Systemic biomarkers Year: 2016 Chronic obstructive pulmonary disease in smokers with asthma Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission Year: 2011 Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Effect of roflumilast on morphological changes in mucous membrane of bronchi in patients with severe chronic obstructive pulmonary disease Source: International Congress 2014 – Predictors Year: 2014 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 "Nitosative stress" in the bronchial mucosa of severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 363s Year: 2005 Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD exacerbations Year: 2014 Airway T-lymphocytes expressing IFN-γ are reduced in smokers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 6s Year: 2002 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 Characteristics and consequences of chronic obstructive pulmonary disease in never smokers Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 Common airway variants and chronic obstructive pulmonary disease Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015 Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Morphological markers of resistance bronchial mucosa of smokers to the development of COPD Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015